Insulin prices could be much lower and drug makers would still make healthy profits
FREDERICK FLORIN/AFP/GETTY IMAGES
As prices for diabetes treatments roil consumers, a study suggests manufacturers could make both human and analog insulins at low costs and still profit.
No hay comentarios:
Publicar un comentario